2-Methyl-3-(thiophen-2-yl)quinoxaline

Catalog No.: 
ACPXLG762
CAS No.: 
1023558-03-3
Molecular Formula: 
C13H10N2S
Molecular Weight: 
226.30
2-Methyl-3-(thiophen-2-yl)quinoxaline structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$102.00InquiryInquiry
5g97%$500.00InquiryInquiry
25g97%$2475.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Methyl-3-(thiophen-2-yl)quinoxaline
IUPAC Name2-methyl-3-(thiophen-2-yl)quinoxaline
Molecular FormulaC13H10N2S
Molecular Weight226.30
SMILESCC1=NC2=CC=CC=C2N=C1C1=CC=CS1
InChI KeyZXZRMFGGDBQQRR-UHFFFAOYSA-N
SynonymQuinoxaline, 2-methyl-3-(2-thienyl)-;2-Methyl-3-(thiophen-2-yl)quinoxaline
CAS No.1023558-03-3

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPXLG762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACASRH902 route compound structure diagram
    ACASRH90232601-86-8In Stock
  2. Plus
  3. ACUXRB496 route compound structure diagram
    ACUXRB4966165-68-0In Stock
  4. Then
  5. ACPXLG762 route product structure diagram
    ACPXLG7621023558-03-3
Inquiry

2. ACPXLG762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACUXRB496 route compound structure diagram
    ACUXRB4966165-68-0In Stock
  4. Then
  5. ACPXLG762 route product structure diagram
    ACPXLG7621023558-03-3
Inquiry

3. ACPXLG762 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACASRH902 route compound structure diagram
    ACASRH90232601-86-8In Stock
  4. Then
  5. ACPXLG762 route product structure diagram
    ACPXLG7621023558-03-3
Inquiry

Comments (0)